城市社區(qū)糖尿病患者不同管理模式實施效果的比較
[Abstract]:Objective to describe three kinds of diabetes management models in urban community health service centers, compare the effects of different diabetes management models on the disease control of diabetic patients, and explore a more effective diabetes management model in urban community. Methods the data of this study and some laboratory data were collected from the Beijing Community Diabetes study, "improving the Model and effectiveness of Diabetes Management in third Class A Hospital and Multi-center Community". 213 patients with type 2 diabetes were managed. According to the principle of simple randomization, the patients were divided into two groups: group 1 and group 2 receiving intensive medical management and group 2 receiving standard medical management. According to the wishes of the patients, patients in group 1 were invited to join the diabetes self-management group for integrated management. They were divided into three groups: standard group, reinforcement group and comprehensive group. This study mainly includes three parts: physical examination, biochemical measurement, diabetes related knowledge and behavior survey and time cost calculation. The data collected included demographic characteristics of the subjects, physiological and biochemical indicators related to diabetes at different stages (body mass index, waist circumference, fasting blood glucose, glycosylated hemoglobin, systolic blood pressure, diastolic blood pressure, triglyceride, total cholesterol, systolic blood pressure, diastolic blood pressure, triglyceride, total cholesterol). Low density lipoprotein cholesterol, high density lipoprotein cholesterol), knowledge and behavior related to management of diabetes mellitus, time cost of different management methods. Statistical description t test, variance analysis and chi-square test were used to analyze the data and evaluate the effect of different management methods. Results for 18 months, fasting blood glucose, glycosylated hemoglobin, total cholesterol and low density lipoprotein cholesterol in the standard group, the fortified group and the comprehensive group showed a decreasing trend, and the decreasing trend in the comprehensive group was higher than that in the fortified group. The standard group decreased the least. After 18 months of management, the differences of fasting blood glucose, glycosylated hemoglobin, triglyceride and total cholesterol between the three groups were statistically significant. The decreasing value of fasting blood glucose in the comprehensive group was higher than that in the strengthening group and the standard group, and the decrease of glycosylated hemoglobin, triglyceride and total cholesterol in the combined group and the fortified group were all higher than those in the standard group, and the difference was statistically significant. In the standard group, the reinforcement group, the comprehensive group, the fasting blood glucose reached the standard rate of 62.86 and 77.03, and the saccharified hemoglobin reached the standard rate of 59.05 and 71.62%, respectively. The chi-square test showed the difference between the three groups was statistically significant. After different management models, the mastery rate of diabetes related knowledge in the three groups was higher than that in the initial study, and the difference of the improvement rate was statistically significant. The improvement rate of diabetes related knowledge in the comprehensive group was higher than that in the reinforcement group, and the improvement rate in the standard group was the lowest. The frequency of blood glucose monitoring, the rate of regular foot examination and the rate of compliance with medicine were all increased in the three groups, and the difference was statistically significant in the average time of each visit in general outpatient clinic of type 2 diabetes mellitus patients from 3 to 8.35 minutes. The diabetes specialist outpatient service was 16.5 minutes, and the diabetes self-management group had an average counseling time of 9.09 minutes per team member. Conclusion the comprehensive management of diabetes mellitus is more beneficial to the control of diabetes disease, improve the rate of fasting blood glucose and glycosylated hemoglobin, and improve the knowledge and skills of diabetes mellitus patients. For the wide-scale promotion of the integrated management model, further economic and time cost accounting is also needed.
【學位授予單位】:中國疾病預防控制中心
【學位級別】:碩士
【學位授予年份】:2015
【分類號】:R587.1
【相似文獻】
相關期刊論文 前10條
1 王玉新,李大啟,李公寶,徐琴君;糖尿病腎病患者血清可溶性白細胞介素6受體檢測[J];上海免疫學雜志;2001年02期
2 宮雅南,劉冬年,熊玉冰,黃偉文,莊萬江;糖尿病足患者糖尿病視網膜病變分析[J];廣東醫(yī)學;2001年06期
3 顧芹,宋守君,李向陽,尤傳一;胰激肽原酶腸溶片對早期糖尿病腎病的防治作用[J];中國臨床藥學雜志;2001年06期
4 曹愛華 ,王瑛 ,李翔;杏丁治療早期糖尿病腎病療效觀察[J];遼寧實用糖尿病雜志;2001年03期
5 ;中藥治療糖尿病腎病新進展[J];中國中醫(yī)藥信息雜志;2001年04期
6 張桂茹;糖尿病腎病85例臨床分析[J];陜西醫(yī)學雜志;2002年02期
7 侯建明 ,林鳳輝 ,張超群;46例2型糖尿病腎病與糖尿病自主神經病變的關系分析[J];福建醫(yī)藥雜志;2002年04期
8 陳文霖;糖尿病飲食[J];醫(yī)療保健器具;2002年Z1期
9 孫力,許玲;2型糖尿病患者糖尿病足的危險因素分析[J];山東醫(yī)藥;2002年35期
10 ;糖尿病腎病診治研究進展[J];基礎醫(yī)學與臨床;2003年04期
相關會議論文 前10條
1 張星;許筠;蘇建平;張軍;程立志;翟曉麗;;糖尿病腎病的臨床療效對比觀察[A];第十九次全國中醫(yī)腎病學術交流會論文匯編[C];2006年
2 楊家茂;;糖尿病腎病防治瑣談[A];全國第二屆中醫(yī)中西醫(yī)結合腎臟病臨床進展學術研討會論文集[C];2007年
3 丁耀耿;郝桂霞;;糖尿病腎病臨床分析[A];全國第二屆中醫(yī)中西醫(yī)結合腎臟病臨床進展學術研討會論文集[C];2007年
4 張文鎧;王志伏;王雪;孫大朋;;糖尿病腎病的治療現狀[A];中華中醫(yī)藥學會第二十一屆全國中醫(yī)腎病學術會議論文匯編(下)[C];2008年
5 倪青;;糖尿病腎病的中西醫(yī)結合研究[A];第六屆全國中西醫(yī)結合腎臟病學術會議論文匯編[C];2000年
6 孫怡;李健紅;宗紅燕;;黃芪桂枝五物湯加味治療糖尿病腎病16例[A];第六屆全國中西醫(yī)結合腎臟病學術會議論文匯編[C];2000年
7 葉軍;;糖尿病腎病在兒童時期的早期干預[A];中華醫(yī)學會第六次全國內分泌學術會議論文匯編[C];2001年
8 杜旭昶;孫志紅;閆春芳;劉彩虹;;疏糖丹治療2型糖尿病50例臨床分析[A];第六次中國中西醫(yī)結合糖尿病學術會議論文匯編[C];2002年
9 于世家;任平;馬麗佳;李小娟;鄭曙琴;武明東;劉自力;薛麗輝;;糖尿病住院患者1344例回顧性分析[A];第六次中國中西醫(yī)結合糖尿病學術會議論文匯編[C];2002年
10 郝效槐;魏玫都;崔立俊;;中西并蓄治療糖尿病腎病[A];第七次中國中西醫(yī)結合糖尿病學術會議論文匯編[C];2004年
相關重要報紙文章 前10條
1 本報記者 向佳;糖尿病中醫(yī)藥防治項目立足社區(qū)[N];中國中醫(yī)藥報;2011年
2 特約記者 魯海燕;逾八成公眾存在糖尿病高危因素[N];家庭醫(yī)生報;2013年
3 馬明愈;現代生活方式導致 糖尿病發(fā)病率迅速上升[N];中國婦女報;2005年
4 省立醫(yī)院內分泌科主任醫(yī)師 侯建明;糖尿病腎病的防治[N];福建科技報;2004年
5 王文絹 范軍星;世界糖尿病日關注焦點:糖尿病并發(fā)癥[N];健康報;2003年
6 主持人 向紅丁博士;糖尿病腎病須早防早治[N];人民政協(xié)報;2002年
7 華悅;預防糖尿病,從減肥開始[N];上海中醫(yī)藥報;2004年
8 劉冬梅;肥胖糖尿病第一誘因[N];天津日報;2004年
9 劉燕玲;首部中醫(yī)專病指南定下糖尿病治則[N];健康報;2007年
10 崔昕;中藥防治糖尿病腎病有進展[N];健康時報;2006年
相關博士學位論文 前10條
1 王曉杰;組蛋白去乙酰化酶4特異性促進糖尿病腎病足細胞損傷[D];山東大學;2015年
2 張永;MiR-346在抗TGF-β信號途徑介導的糖尿病腎病發(fā)生和發(fā)展中的作用機制[D];武漢大學;2015年
3 魏鳳江;高尿酸血癥、2型糖尿病及糖尿病微血管病變的群體遺傳學研究[D];天津醫(yī)科大學;2015年
4 孫士杰;胱抑素C對2型糖尿病視網膜病變預測價值研究[D];山東大學;2015年
5 魏艷紅;PKCα介導的EGFR降解在糖尿病腎病足細胞損傷中的作用及機制[D];華中科技大學;2015年
6 龍泓竹;益氣養(yǎng)陰通絡散結方防治早期糖尿病腎病的臨床及實驗研究[D];北京中醫(yī)藥大學;2016年
7 姜e,
本文編號:2254694
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2254694.html